早期帕金森病中脑深部电刺激对静止性震颤进展的影响
该研究为早期帕金森病脑深部电刺激(DBS)先导试验的事后分析,纳入28例患者随机接受最佳药物治疗(ODT)或DBS联合ODT。结果显示,ODT组UPDRS-III「关」期静止性震颤评分从基线至24个月恶化程度较DBS+ODT组更严重(p=0.002),且DBS+ODT组静止性震颤斜率在「关」期和「开」期均更优。作者认为早期DBS可能减缓静止性震颤进展,需更大队列研究验证。
要点
- 早期帕金森病患者中,ODT组UPDRS-III「关」期静止性震颤评分从基线至24个月恶化程度较DBS+ODT组更严重(p=0.002)。
- DBS+ODT组静止性震颤斜率在「关」期和「开」期均优于ODT组(p<0.001,p=0.003)。
- ODT组更多患者出现新发静止性震颤(p=0.001),DBS可能减缓早期帕金森病静止性震颤进展。
核心结论
- 早期帕金森病中DBS可能减缓静止性震颤进展;需更大队列研究验证,并将在美国食品药品监督管理局批准的III期多中心关键临床试验中检验。
研究设计与样本
- 早期帕金森病DBS先导试验的事后分析,前瞻性纳入50-75岁、药物治疗6个月至4年、无运动障碍或运动波动的帕金森病患者,随机接受最佳药物治疗(ODT)或DBS联合ODT(DBS+ODT),共28例。
主要发现
- UPDRS-III「关」期静止性震颤评分从基线至24个月的变化在ODT组较DBS+ODT组更差(p=0.002)。
- 从基线至24个月的静止性震颤斜率在「关」期和「开」期均有利于DBS+ODT组(p<0.001,p=0.003)。
- ODT组较DBS+ODT组更多患者出现新发静止性震颤(p=0.001)。
关键数值与推荐
- 本研究提供II级证据表明,对于早期帕金森病患者,DBS可能减缓静止性震颤进展。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether the progression of individual motor features was influenced by early deep brain stimulation (DBS), a post hoc analysis of Unified Parkinson's Disease Rating Scale-III (UPDRS-III) score (after a 7-day washout) was conducted from the 2-year DBS in early Parkinson disease (PD) pilot trial dataset. METHODS: The prospective pilot trial enrolled patients with PD aged 50-75 years, treated with PD medications for 6 months-4 years, and no history of dyskinesia or other motor fluctuations, who were randomized to receive optimal drug therapy (ODT) or DBS plus ODT (DBS + ODT). At baseline and 6, 12, 18, and 24 months, all patients stopped all PD therapy for 1 week (medication and stimulation, if applicable). UPDRS-III "off" item scores were compared between the ODT and DBS + ODT groups (n = 28); items with significant between-group differences were analyzed further. RESULTS: UPDRS-III "off" rest tremor score change from baseline to 24 months was worse in patients receiving ODT vs DBS + ODT (p = 0.002). Rest tremor slopes from baseline to 24 months favored DBS + ODT both "off" and "on" therapy (p < 0.001, p = 0.003, respectively). More ODT patients developed new rest tremor in previously unaffected limbs than those receiving DBS + ODT (p = 0.001). CONCLUSIONS: These results suggest the possibility that DBS in early PD may slow rest tremor progression. Future investigation in a larger cohort is needed, and these findings will be tested in the Food and Drug Administration-approved, phase III, pivotal, multicenter clinical trial evaluating DBS in early PD. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that for patients with early PD, DBS may slow the progression of rest tremor.
引用
- Hacker ML, DeLong MR, Turchan M, et al. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease. Neurology. 2018. PMID: 29959266. doi:10.1212/WNL.0000000000005903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。